Michael Berelowitz, Director at ORAMED PHARMACEUTICALS INC. (ORMP), sold 700 shares at $9.44 ($7K) on 2015-12-09, disclosed to the SEC on 2015-12-10.
Open-market sale of $7k ORMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2014-04-02 | $99K | — | Filing → |